Judges Scientific Regulatory News (JDG)

Judges Scientific plc (the "Company")

22 July 2014

Director/PDMR Shareholding

Judges Scientific plc has been notified of transactions in the share capital of the Company by two Directors, as set out below. None of these transactions alters the respective beneficial interests of the Directors concerned.

Through his SIPP, Ralph Elman, a Non-Executive Director of the Company, gave the requisite 30 days' notice on Friday 18 July 2014 to convert 208,333 Convertible Redeemable shares (being the entirety of the outstanding share capital in the Company of that class) into 29,969 new Ordinary Shares of 5p each in the Company ("Ordinary Shares"). The amount payable to the Company in respect of the conversion is £26,387. Following the completion of this transaction, his interest in the Ordinary Shares, including those held in his SIPP, will increase to 62,398 shares representing 1.04% of the issued share capital of that class as increased by the conversion set out above.

On 21 July 2014 David Cicurel, the Chief Executive Officer of the Company, sold 15,000 Ordinary Shares to his SIPP at a price of 1307.50p per share. His interest in the share capital of the Company is unaltered at 916,456 Ordinary Shares representing 15.37 per cent of the issued Ordinary share capital. In addition, he holds options over 1,775 Ordinary Shares under the Company's Share Option Plans.

For further information please contact:

Judges Scientific plc

David Cicurel, CEO

Tel: 01342 323 600

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

Cardew Group (Financial Public Relations)

Melvyn Marckus

Tel: 020 7930 0777 or 07775 896 491

Website:

Judges Scientific: www.judges.uk.com